OncoMed Pharmaceuticals Inc Form 425: Prospectus or communication for a business combination

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2019-04-17: Form 425; Description 8-K; Document d722464d8k.htm.
2019-03-15: Form 425; Description FORM 8-K; Document d709280d8k.htm.
2019-03-15: Form 425; Description FORM 425; Document dp103777_425.htm.
2019-03-12: Form 425; Description FORM 425; Document dp103622_425.htm.

Filed	Form	Description	Document
2019-04-17	425	8-K	d722464d8k.htm
2019-03-15	425	FORM 8-K	d709280d8k.htm
2019-03-15	425	FORM 425	dp103777_425.htm
2019-03-12	425	FORM 425	dp103622_425.htm
2019-02-22	425	FORM 425	dp102587_425.htm
2019-02-15	425	FORM 425	dp102364_425.htm
2019-02-12	425	FORM 425	dp102205_425.htm
2019-02-11	425	425	d705419d425.htm
2019-01-07	425	FORM 425	dp100593_425.htm
2018-12-11	425	FORM 425	dp99454_425.htm
2018-12-06	425	8-K	d665634d8k.htm
2018-12-06	425	FORM 425	dp99393_425-3.htm
2018-12-06	425	FORM 425	dp99392_425-2.htm
2018-12-06	425	FORM 425	dp99391_425.htm
2018-12-06	425	FORM 425	dp99402_425-4.htm